CN103351383A - 5-氟尿嘧啶氮氧自由基抗肿瘤药物 - Google Patents

5-氟尿嘧啶氮氧自由基抗肿瘤药物 Download PDF

Info

Publication number
CN103351383A
CN103351383A CN2013103219497A CN201310321949A CN103351383A CN 103351383 A CN103351383 A CN 103351383A CN 2013103219497 A CN2013103219497 A CN 2013103219497A CN 201310321949 A CN201310321949 A CN 201310321949A CN 103351383 A CN103351383 A CN 103351383A
Authority
CN
China
Prior art keywords
compound
fluorouracil
cell
cancer
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013103219497A
Other languages
English (en)
Chinese (zh)
Other versions
CN103351383B (zh
Inventor
贾艳艳
孙晓莉
文爱东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fourth Military Medical University FMMU
Original Assignee
Fourth Military Medical University FMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fourth Military Medical University FMMU filed Critical Fourth Military Medical University FMMU
Priority to CN201310321949.7A priority Critical patent/CN103351383B/zh
Publication of CN103351383A publication Critical patent/CN103351383A/zh
Application granted granted Critical
Publication of CN103351383B publication Critical patent/CN103351383B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

CN201310321949.7A 2013-07-29 2013-07-29 5-氟尿嘧啶氮氧自由基抗肿瘤药物 Expired - Fee Related CN103351383B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310321949.7A CN103351383B (zh) 2013-07-29 2013-07-29 5-氟尿嘧啶氮氧自由基抗肿瘤药物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310321949.7A CN103351383B (zh) 2013-07-29 2013-07-29 5-氟尿嘧啶氮氧自由基抗肿瘤药物

Publications (2)

Publication Number Publication Date
CN103351383A true CN103351383A (zh) 2013-10-16
CN103351383B CN103351383B (zh) 2015-03-25

Family

ID=49307818

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310321949.7A Expired - Fee Related CN103351383B (zh) 2013-07-29 2013-07-29 5-氟尿嘧啶氮氧自由基抗肿瘤药物

Country Status (1)

Country Link
CN (1) CN103351383B (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106074556A (zh) * 2016-06-14 2016-11-09 河南师范大学 L型胞嘧啶丙氨酸在制备抗癌药物中的应用
CN106397439A (zh) * 2016-09-11 2017-02-15 兰州大学 一种自旋标记骆驼宁碱a化合物、制备方法及其用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1743316A (zh) * 2004-09-03 2006-03-08 首都医科大学 2－取代苯基－4,4,5,5－四甲基－1,3－二氧基咪唑啉，它们的制备及在药物制备中的应用
CN102070532A (zh) * 2011-01-25 2011-05-25 中国人民解放军第四军医大学 抗肿瘤药物结构
CN102070615A (zh) * 2011-01-25 2011-05-25 中国人民解放军第四军医大学 氮氧自由基抗肿瘤药物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1743316A (zh) * 2004-09-03 2006-03-08 首都医科大学 2－取代苯基－4,4,5,5－四甲基－1,3－二氧基咪唑啉，它们的制备及在药物制备中的应用
CN102070532A (zh) * 2011-01-25 2011-05-25 中国人民解放军第四军医大学 抗肿瘤药物结构
CN102070615A (zh) * 2011-01-25 2011-05-25 中国人民解放军第四军医大学 氮氧自由基抗肿瘤药物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
XIANGYANG QIN ET AL.: "Preparation and characterization of new chiral pyrrolyl α-nitronyl nitroxide radicals in which the imidazolyl framework was directly bound to chiral center", 《JOURNAL OF MOLECULAR STRUCTURE》, vol. 989, 14 January 2011 (2011-01-14), pages 10 - 19, XP028183315, DOI: doi:10.1016/j.molstruc.2010.12.024 *
XIANGYANG QIN: "Synthesis ,characterisation,cytotoxicity and radioprotective effect of novel chiral nitronyl nitroxyl radicals", 《JOURNAL OF CHEMICAL RESEARCH》, 31 August 2009 (2009-08-31), pages 511 - 514 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106074556A (zh) * 2016-06-14 2016-11-09 河南师范大学 L型胞嘧啶丙氨酸在制备抗癌药物中的应用
CN106074556B (zh) * 2016-06-14 2018-11-16 河南师范大学 L型胞嘧啶丙氨酸在制备抗癌药物中的应用
CN106397439A (zh) * 2016-09-11 2017-02-15 兰州大学 一种自旋标记骆驼宁碱a化合物、制备方法及其用途

Also Published As

Publication number Publication date
CN103351383B (zh) 2015-03-25

Similar Documents

Publication Publication Date Title
CN105622674B (zh) 一类含有生物活性基团的四价铂配合物及其制备方法
CN104447777B (zh) 一种辣椒碱-喜树碱类抗癌药物偶联物及其制备方法和应用
CN107721959A (zh) 杨梅素衍生物及制备方法，及其在治疗结肠炎、防治结肠炎癌转化和治疗结直肠癌中的应用
CN104163823B (zh) 一种喜树碱与青蒿琥酯偶联物及其制备方法与应用
CN107556361A (zh) 裂环羽扇豆烷衍生物及其抗肿瘤用途
CN110938032A (zh) 有机硒化合物及其用途
CN104013636B (zh) 瓦草五环三萜皂苷类化合物抗肿瘤的药物用途
CN104592091B (zh) 一种含吲哚乙酸核心结构的化合物及其应用
CN103351383B (zh) 5-氟尿嘧啶氮氧自由基抗肿瘤药物
CN110041375A (zh) 具有不对称单取代萘酰亚胺四价铂结构的化合物、制备方法及其在制备抗肿瘤药物中的应用
CN101940569B (zh) 含有索拉非尼和青蒿素及青蒿素类衍生物的药物组合物及其在制备治疗癌症的药物中的应用
CN102688489B (zh) 含有雷公藤甲素及雷公藤甲素类衍生物和Bcl-2抑制剂的药物组合物及其应用
CN106317033A (zh) 一种水飞蓟宾23‑取代衍生物及其注射剂的制备方法和用途
CN108030777B (zh) 氯胍在制备抗肿瘤药物中的应用
CN110938033A (zh) 硒氰化合物及其用途
CN101824065B (zh) 人参皂苷次级苷Rh1的脂肪酸单酯类化合物及制备方法
CN103483187B (zh) 4-乙氧基-2-羟基-6-甲基苯甲酸及其药用组合物和应用
CN107286123A (zh) 一种二苯呋喃类化合物的制备方法与应用
CN113527391A (zh) 一种梓醇衍生物及其制备方法和应用
CN102786458B (zh) 吡咯甲酰胺衍生物、其制备方法和用途
CN104829679B (zh) 一类水溶性南蛇藤素衍生物及其用途
CN103992289B (zh) 取代噻唑烷氨荒酸铋配合物及其用途
CN108997436A (zh) 一种新型瑞格非尼抗肿瘤铂(ii)配合物及其制备方法与应用
TW202007680A (zh) 治療大腸直腸癌的化合物
CN104098646B (zh) 纤细薯蓣皂苷衍生物及其抗肿瘤活性应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150325

Termination date: 20160729